Swedish medical device company Bactiguard AB (STO:BACTIB) announced on Friday a new distribution agreement with Schülke & Mayr GmbH (schülke), a German provider of infection prevention and hygiene solutions.
Under the agreement schülke will distribute Bactiguard's range of wound care solutions to German hospitals.
This collaboration enables schülke to complement its comprehensive product range of antiseptic and wound care products with Bactiguard's hypochlorous acid-based portfolio.
The German launch is scheduled for the third quarter of 2021.
TELA Bio launches LIQUIFIX for US hernia surgery
Cognizant and NVIDIA partner to revolutionize drug discovery with generative AI
Neupulse raises funds for Tourettes Syndrome wearable tech
Bonesupport gains FDA clearance for CERAMENT G in open fractures
Epitomee submits Weight Loss Capsule for FDA approval in US
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon